Plus, news about Angelini Pharma, Sovargen, Merck, Eupraxia, Santhera, Lexicon, Seres Therapeutics and MaxCyte:
🇪🇸 Invivo Partners targets €100M fourth fund: The firm plans to raise capital to continue investing at the “intersection of AI ...
↧